Skip to content

Clinical trials

Phase 1 Demyelinating Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Phase: Phase 1 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20162
20182
20212
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Withdrawn3
Recruiting2
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
Accure Therapeutics1
Biogen1
Contineum Therapeutics1
Department of Medical Services Ministry of Public Health of Thailand1
Healeon Medical Inc1
Indapta Therapeutics, INC.1
MGAM LLC1
Robert Fox1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases13
Multiple Sclerosis7
Autoimmune Diseases3
Multiple Sclerosis, Chronic Progressive3
Nervous System Diseases3
Alzheimer Disease2
Autoimmune Diseases of the Nervous System2
Demyelinating Autoimmune Diseases, CNS2
Immune System Diseases2
Adrenoleukodystrophy1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.